The primary human hepatocytes were kindly provided by D. Stroka (University of Bern). Primary human hepatocytes were isolated from wedges of resected liver tissues taken from patients undergoing liver surgery. Written informed consent was obtained prior to surgery in compliance with the local ethical committee [27 (link)]. Cultures from 8 donors were prepared and cultured according to Rencurel et al. [28 (link)]. Additional primary human hepatocytes (5 donors) were purchased from ScienCell Research Laboratories (Carlsbad, CA, USA) and incubated with LPS and cell viability and respiration rates of intact cells were analyzed.
Hepg2
HepG2 is a well-established human liver cancer cell line derived from the liver tissue of a 15-year-old Caucasian male. This cell line is widely used in various research applications, including the study of liver metabolism, drug toxicity, and cancer biology.
Lab products found in correlation
16 protocols using hepg2
Culturing and Analyzing Human Hepatocellular Carcinoma and Primary Hepatocytes
The primary human hepatocytes were kindly provided by D. Stroka (University of Bern). Primary human hepatocytes were isolated from wedges of resected liver tissues taken from patients undergoing liver surgery. Written informed consent was obtained prior to surgery in compliance with the local ethical committee [27 (link)]. Cultures from 8 donors were prepared and cultured according to Rencurel et al. [28 (link)]. Additional primary human hepatocytes (5 donors) were purchased from ScienCell Research Laboratories (Carlsbad, CA, USA) and incubated with LPS and cell viability and respiration rates of intact cells were analyzed.
Evaluating HepG2 Cell Viability in Inflammation
Culturing HepG2 and MCF-7ΔAHR Cells
HCC Cell Culture and Transfection
Cell Culture Conditions for Cancer Cell Lines
Cells were cultured as described previously [36 (link)]. In detail, MCF-7 in RPMI medium containing 10% fetal bovine serum (FBS), 1 mM sodium pyruvate, and 0.1 M nonessential amino acids (NEAA); HeLa and HepG2 in RPMI medium containing 10% FBS and 2 mM Glutamax; MDA-MB-231 in Leibovitz’s L15 with 10% FBS; HCT116 and SK-BR-3 in McCoy’s 5A medium containing 10% FBS and 2 mM Glutamax; and LNCap in RPMI medium containing 10% FBS, 1 mM sodium pyruvate, 0.1 M NEAA, 2 mM Glutamax, and 0.01 M HEPES. All cell culture media were used without antibiotics. MCF-7, HCT116, SK-BR-3, LNCap, HeLa, and HepG2 were maintained at 37 °C in a humidified incubator with a 5% CO2 atmosphere and MDA-MB-231 cells were handled without gaseous exchange. The absence of mycoplasma in the cell culture was regularly tested using the Venor GeM qOneStep-Kit (Minerva-biolabs, Berlin, Germany).
Genotoxicity evaluation of lignans
Syringaresinol (4,4′-(1S,3aR,4S,6aR)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diylbis(2,6-dimethoxy-phenol); Syr) was purchased from BOC Science (NewYork, USA). Enterodiol ((2R,3R)-2,3-bis[(3-hydroxyphenyl)methyl]butane-1,4-diol; END), enterolactone ((3R,4R)-3,4-bis[(3-hydroxyphenyl) methyl]oxolan-2-one; ENL), dimethyl sulfoxide (DMSO) 99,6%, sodium dodecylsulfate (SDS), absolute ethanol (≥99.8%), trypan blue solution, resazurin, and ethidium bromide were obtained from Sigma-Aldrich (Munich, Germany). Low and normal melting agarose were obtained from Bio-Rad (Munich, Germany), and trypsin was obtained from Serva (Heidelberg, Germany). Cell culture media (RPMI 1640, DMEM) were purchased from Thermo Fisher Scientific (Dreieich, Germany) while the supplements fetal calf serum (FCS) and penicillin/streptomycin (P/S) were obtained from Invitrogen (Karlsruhe, Germany). Cell culture materials (petri dishes, flasks, etc.) were acquired from Greiner Bio-One (Essen, Germany). The cell lines HepG2 and HT29 were purchased from DSMZ (Braunschweig, Germany).
Sorafenib and Perhexiline Inhibit HepG2 Proliferation
Cell Line Culturing and Maintenance
Cytokine and Inhibitor Treatment of HepG2 Cells
Cell Culture for Cancer Assays
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!